Phase 2 trial of daratumumab, cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma

Authors:

Abstract
No abstract available
Funding Information
  • Cilag

This publication has 31 references indexed in Scilit: